scispace - formally typeset
J

José Artur Paiva

Researcher at University of Porto

Publications -  153
Citations -  3952

José Artur Paiva is an academic researcher from University of Porto. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 26, co-authored 118 publications receiving 2510 citations.

Papers
More filters
Journal ArticleDOI

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper .

Mohd H. Abdul-Aziz, +20 more
- 07 May 2020 - 
TL;DR: Routine TDM is recommended to be performed for aminoglycosides, beta-lactam antibiotics, linezolid, teicoplanin, vancomycin and voriconazole in critically ill patients.
Journal ArticleDOI

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study

Alexis Tabah, +26 more
- 26 Sep 2012 - 
TL;DR: Intensified efforts to prevent HA-BSIs and to optimize their management through adequate source control and antibiotic therapy are needed to improve outcomes.
Journal ArticleDOI

Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes

Fabio Silvio Taccone, +13 more
- 12 Jan 2015 - 
TL;DR: Patients diagnosed with proven or putative IA had greater severity of illness and more frequently needed organ support than those with Aspergillus spp colonization, and IA among critically ill patients is associated with high mortality.
Journal ArticleDOI

International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia.

Jordi Rello, +12 more
- 01 Sep 2001 - 
TL;DR: A consensus conference attended by 12 researchers from Europe and Latin America was held to discuss strategies for the diagnosis and treatment of VAP, with consensus on the importance of local epidemiology surveillance programs and on the need for customized empiric antimicrobial choices to respond to local patterns of pathogens and susceptibilities.
Journal ArticleDOI

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

Florence Ader, +163 more
- 14 Sep 2021 - 
TL;DR: The DisCoVeRy trial as mentioned in this paper evaluated the clinical efficacy of remdesivir plus standard care compared with standard of care alone in patients admitted to hospital with COVID-19, with indication of oxygen or ventilator support.